Comments on: Pharmalot… Pharmalittle… Good Morning http://www.pharmalot.com/2008/12/pharmalot-pharmalittle-good-morning-127/ News, Comment and Conversation Fri, 10 Feb 2012 21:55:51 +0000 http://wordpress.org/?v=2.6.2 By: Peter http://www.pharmalot.com/2008/12/pharmalot-pharmalittle-good-morning-127/#comment-384890 Peter Wed, 17 Dec 2008 02:34:26 +0000 http://www.pharmalot.com/?p=18587#comment-384890 Nathan - The announcement of increasing R & D expenditures made by BayerAG covers more than just their pharmaceuticals. The article also suggests increased R & D expenditures in the areas of MaterialScience and CropScience. For example: "Between 2008 and 2012, Bayer CropScience intends to invest a total of EUR 3.4 billion in research and development." At the same time, Bayer also states they are looking for additional tax breaks and increased patent protections. Nathan -
The announcement of increasing R & D expenditures made by BayerAG covers more than just their pharmaceuticals. The article also suggests increased R & D expenditures in the areas of MaterialScience and CropScience.

For example: “Between 2008 and 2012, Bayer CropScience intends to invest a total of EUR 3.4 billion in research and development.”

At the same time, Bayer also states they are looking for additional tax breaks and increased patent protections.

]]> By: Ed Silverman http://www.pharmalot.com/2008/12/pharmalot-pharmalittle-good-morning-127/#comment-384708 Ed Silverman Mon, 15 Dec 2008 14:22:39 +0000 http://www.pharmalot.com/?p=18587#comment-384708 Hi Nathan, Yes, this is the same company. Here is the staetement Bayer issued on Friday... http://www.bayer.com/en/News-Detail.aspx?id=11455 As to your question, which is a good one, I can only say 'what a difference two years can make.' However, the Bayer statement is short on specifics, unfortunately, so I don't have a good answer. I've not seen a report from the press conference in Germany that offered further details either, although I will check. Regards ed Hi Nathan,

Yes, this is the same company. Here is the staetement Bayer issued on Friday…

http://www.bayer.com/en/News-Detail.aspx?id=11455

As to your question, which is a good one, I can only say ‘what a difference two years can make.’ However, the Bayer statement is short on specifics, unfortunately, so I don’t have a good answer. I’ve not seen a report from the press conference in Germany that offered further details either, although I will check.

Regards
ed

]]> By: Nathan http://www.pharmalot.com/2008/12/pharmalot-pharmalittle-good-morning-127/#comment-384701 Nathan Mon, 15 Dec 2008 13:38:40 +0000 http://www.pharmalot.com/?p=18587#comment-384701 Isn't it a little odd for Bayer to be announcing an increase in R&D spending less than a year after it closed two sites of R&D operations in the US? (link below) http://www.forbes.com/markets/feeds/afx/2006/11/09/afx3160321.html (although I'm a bit confused about whether Bayer AG is the same as the Bayer in the pharmatimes article linked by Ed) Isn’t it a little odd for Bayer to be announcing an increase in R&D spending less than a year after it closed two sites of R&D operations in the US? (link below)

http://www.forbes.com/markets/feeds/afx/2006/11/09/afx3160321.html

(although I’m a bit confused about whether Bayer AG is the same as the Bayer in the pharmatimes article linked by Ed)

]]>